Skip to ContentSkip to Navigation
About us Latest news News News articles

Renal disease progression in autosomal dominant polycystic kidney disease. A role for vasopressin?

05 January 2011

PhD ceremony: Ms. E. Meijer, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen

Title: Renal disease progression in autosomal dominant polycystic kidney disease. A role for vasopressin?

Promotor(s): prof. P.E. de Jong

Faculty: Medical Sciences

 

This thesis (divided into three parts) focuses on markers of disease severity in ADPKD, on a potential detrimental role of endogenous vasopressin and on the applicability of V2RA in ADPKD. Part 1 illustrates that renal function is not an appropriate marker for disease severity in an early stage of ADPKD. Renal blood flow, renal volume and NGAL (a urinary damage marker) could be measured instead. In part 2, we found indications that indeed endogenous vasopressin can have a detrimental role in causing renal damage in healthy subjects, in renal transplant recipients and in ADPKD patients. In part 3, the study design of a randomized controlled trial investigating the efficacy of V2RA in ADPKD is discussed.

Last modified:13 March 2020 01.11 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.